01

Revenues generated from bargaining are reinvested into further R&D. Cystic Fibrosis Foundation Therapeutics sold its Vertex patent royalty stream to Royalty Pharma for $3.3bn, using the revenue to further cystic fibrosis drug development. Source: Royal Pharma